Welcome! If you’re innovating biotech, our team is here to help you protect, commercialize and grow your ideas. Explore the resources below, curated for Bayer Co.Lab Vendor Showcase attendees.
Resources
Publications & Insights
- Intellectual Property – Quick Tips for Businesses (PDF)
- Oligonucleotide Therapeutics Patenting: Strategies for Success (subscription required)
- Federal Circuit Decision Highlights the Risks of Inconsistency from Provisional to Patent
- Federal Circuit Says Claim Cancellation Can Create Prosecution History Estoppel
- Liability Considerations for Developers and Users of Agentic AI Systems
- Track One Expansion: A Strategic Opportunity Amid USPTO Delays
- Purdue Case Could Transform Patent Obviousness Analyses (subscription required)
- Claim Construction Matters: Federal Circuit Decision Highlights the Significance of Lexicography in Patent Drafting
- “Restoring Gold Standard Science” Executive Order – Potential Impacts for Patent Applicants and Owners
- Trump Executive Order Restricts Funding for “Dangerous Gain-of-Function Research”
More About Our IP practice
- Lathrop GPM Intellectual Property Attorneys (PDF)
- Intellectual Property
- Patents
- Life Sciences
- Licensing & Commercial Transactions
- Intellectual Property Diligence
Connect With Us
- Follow our LinkedIn page
- Subscribe to future alerts and news
Vendor Showcase Representative
Michael J. Spellberg, Ph.D.
Partner, Boston